Lite Strategy, Inc. (LITS)
NASDAQ: LITS · Real-Time Price · USD
0.9940
+0.0085 (0.86%)
At close: Sep 1, 2026, 4:00 PM EDT
1.010
+0.016 (1.61%)
After-hours: Sep 1, 2026, 7:30 PM EDT
Lite Strategy Market Cap
Lite Strategy has a market cap or net worth of $33.82 million as of September 1, 2026. Its market cap has increased by 4.39% in one year.
Market Cap
33.82M
Enterprise Value
26.28M
1-Year Change
4.39%
Ranking
Category
Stock Price
$0.99
ChartMarket Cap Chart
Since December 18, 2003, Lite Strategy's market cap has decreased from $424.10M to $33.82M, a decrease of -92.03%. That is a compound annual growth rate of -10.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 33.82M | -30.41% |
| Dec 31, 2025 | 48.60M | 196.34% |
| Dec 31, 2024 | 16.40M | -57.51% |
| Dec 29, 2023 | 38.60M | 18.77% |
| Dec 30, 2022 | 32.50M | -89.20% |
| Dec 31, 2021 | 301.00M | 1.31% |
| Dec 31, 2020 | 297.10M | 62.62% |
| Dec 31, 2019 | 182.70M | -2.72% |
| Dec 31, 2018 | 187.80M | 141.70% |
| Dec 29, 2017 | 77.70M | 46.60% |
| Dec 30, 2016 | 53.00M | -2.93% |
| Dec 31, 2015 | 54.60M | -40.85% |
| Dec 31, 2014 | 92.30M | -46.40% |
| Dec 31, 2013 | 172.20M | 580.63% |
| Dec 31, 2012 | 25.30M | 105.69% |
| Dec 30, 2011 | 12.30M | 73.24% |
| Dec 31, 2010 | 7.10M | -86.19% |
| Dec 31, 2009 | 51.40M | - |
| Dec 31, 2008 | 51.40M | -74.17% |
| Dec 31, 2007 | 199.00M | 2.58% |
| Dec 29, 2006 | 194.00M | -45.49% |
| Dec 30, 2005 | 355.90M | -30.12% |
| Dec 31, 2004 | 509.30M | -23.48% |
| Dec 31, 2003 | 665.60M | 56.94% |
| Dec 18, 2003 | 424.10M | - |
View and export this data all the way back to 2003. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CervoMed | 39.31M |
| TransCode Therapeutics | 36.91M |
| Context Therapeutics | 35.25M |
| Quince Therapeutics | 34.33M |
| Veraxa Biotech AG | 34.04M |
| BriaCell Therapeutics | 32.50M |
| Kyntra Bio | 32.47M |
| IGC Pharma | 32.05M |